Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer

Oncology Reports

Volumn 27, Issue 4, 2012, Pages 1156-1162

  Wang, Yu ^a   Wang, Yunxia ^a   Shen, Liang ^a   Pang, Yingxin ^a   Qiao, Zhen ^a   Liu, Peishu ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

ATP citrate lyase; Ovarian cancer; Prognosis; RNAi; SREBP 1

Indexed keywords

ADENOSINE TRIPHOSPHATE CITRATE LYASE; SMALL INTERFERING RNA;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER TISSUE; CARCINOGENESIS; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; PRIORITY JOURNAL; RNA INTERFERENCE; TISSUE DISTRIBUTION;

ATP CITRATE (PRO-S)-LYASE; BLOTTING, WESTERN; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CHINA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PHOSPHORYLATION; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTORS; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84863071066     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1638     Document Type: Article

References (30)

1. Warburg O: On the origin of cancer cells. Science 123: 309-314, 1956.
2. Mashima T, Seimiya H and Tsuruo T: De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. Br J Cancer 100: 1369-1372, 2009.
3. Furuta E, Okuda H, Kobayashi A and Watabe K: Metabolic genes in cancer: their roles in tumor progression and clinical implications. Biochim Biophys Acta 1805: 141-152, 2010.
4. Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR and Thompson CB: ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324: 1076-1080, 2009.
5. Hatzivassiliou G, Zhao F, Bauer DE, et al: ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8: 311-321, 2005. (Pubitemid 41443416)
6. Bauer DE, Hatzivassiliou G, Zhao F, Andreadis C and Thompson CB: ATP citrate lyase is an important component of cell growth and transformation. Oncogene 24: 6314-6322, 2005. (Pubitemid 43080054)
7. Migita T, Narita T, Nomura K, et al: ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. Cancer Res 68: 8547-8554, 2008.
8. Beckner ME, Fellows-Mayle W, Zhang Z, et al: Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas. Int J Cancer 126: 2282-2295, 2010.
9. Zhou W, Han WF, Landree LE, et al: Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells. Cancer Res 67: 2964-2971, 2007. (Pubitemid 46724832)
10. Iorio E, Mezzanzanica D, Alberti P, et al: Alterations of choline phospholipid metabolism in ovarian tumor progression. Cancer Res 65: 9369-9376, 2005. (Pubitemid 41508005)
11. Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108, 2008. (Pubitemid 351818697)
12. Kuhajda FP: Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 16: 202-208, 2000.
13. Ookhtens M, Kannan R, Lyon I and Baker N: Liver and adipose tissue contributions to newly formed fatty acids in an ascites tumor. Am J Physiol 247: R146-R153, 1984. (Pubitemid 14090895)
14. Swinnen JV, Brusselmans K and Verhoeven G: Increassed lipogenesis in cancer cells: new players, novel target. Curr Opin Clin Nutr Metab Care 9: 358-365, 2006. (Pubitemid 44101970)
15. Pelicano H, Martin DS, Xu RH and Huang P: Glycolysis inhibition for anticancer treatment. Oncogene 25: 4633-4646, 2006. (Pubitemid 44187614)
16. Luo J, Manning BD and Cantley LC: Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4: 257-262, 2003. (Pubitemid 37329790)
17. Mazzoletti M and Broggini M: PI3K/AKT/mTOR inhibitors in ovarian cancer. Curr Med Chem 17: 4433-4447, 2010.
18. Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C and Gonzalez-Baron M: PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 30: 193-204, 2004.
19. Bababeygy SR, Polevaya NV, Youssef S, et al: HMG-CoA reductase inhibition causes increased necrosis and apoptosis in an in vivo mouse glioblastoma multiforme model. Anticancer Res 29: 4901-4908, 2009.
20. Relja B, Meder F, Wilhelm K, Henrich D, Marzi I and Lehnert M: Simvastatin inhibits cell growth and induces apoptosis and G0/G1 cell cycle arrest in hepatic cancer cells. Int J Mol Med 26: 735-741, 2010.
21. Walter K, Hong SM, Nyhan S, et al: Serum fatty acid synthase as a marker of pancreatic neoplasia. Cancer Epidemiol Biomarkers Prev 18: 2380-2385, 2009.
22. Migita T, Ruiz S, Fornari A, et al: Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst 101: 519-532, 2009.
23. Hilvo M, Denkert C, Lehtinen L, et al: Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression. Cancer Res 71: 3236-3245, 2011.
24. Wang C, Xu C, Sun M, Luo D, Liao DF and Cao D: Acetyl-CoA carboxylase-alpha inhibitor TOFA induces human cancer cell apoptosis. Biochem Biophys Res Commun 385: 302-306, 2009.
25. Turyn J, Schlichtholz B, Dettlaff-Pokora A, et al: Increased activity of glycerol 3-phosphate dehydrogenase and other lipogenic enzymes in human bladder cancer. Horm Metab Res 35: 565-569, 2003. (Pubitemid 37445321)
26. Szutowicz A, Kwiatkowski J and Angielski S: Lipogenetic and glycolytic enzyme activities in carcinoma and nonmalignant diseases of the human breast. Br J Cancer 39: 681-687, 1979. (Pubitemid 9200733)
27. Yahagi N, Shimano H, Hasegawa K, et al: Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma. Eur J Cancer 41: 1316-1322, 2005. (Pubitemid 40813009)
28. Varis A, Wolf M, Monni O, et al: Targets of gene amplification and overexpression at 17q in gastric cancer. Cancer Res 62: 2625-2629, 2002.
29. Moon YA, Lee JJ, Park SW, Ahn YH and Kim KS: The roles of sterol regulatory element-binding proteins in the transactivation of the rat ATP citrate-lyase promoter. J Biol Chem 275: 30280-30286, 2000.
30. Sato R, Okamoto A, Inoue J, et al: Transcriptional regulation of the ATP citrate-lyase gene by sterol regulatory element-binding proteins. J Biol Chem 275: 12497-12502, 2000. (Pubitemid 30241393)